glp 1 microdosing menopause GLP-1 for Perimenopause: Benefits & Risks GLP-1 Microdosing During Menopause: Is

Direct Myocardial Effects Although the presence of functional GLP-1 receptors on human ventricular cardiomyocytes remains a matter of debate, preclinical studies suggest potential direct cardioprotective effects

This creates a potential conflict between therapy goals

GLP-1 medications slow gastric emptying, which may affect how quickly your body absorbs thyroid hormone replacement

The unprecedented demand for GLP-1 receptor agonists is driving pharmaceutical companies to invest heavily in peptide API production, fill-finish facilities, and injectable manufacturing capacity

Discuss all medications with your clinician